Specialties
Reports that name this provider
- Stem Cell Therapy Availability in Brazil
- Leading FAPESP-funded stem cell research center. Associated with Nutera pharmaceutical-grade GMP manufacturing plant (opened 2022) in partnership with Butantan Institute.